Biol Reprod Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow My Folders
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bowen, J. M.
Right arrow Articles by Landis Keyes, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bowen, J. M.
Right arrow Articles by Landis Keyes, P.
Agricola
Right arrow Articles by Bowen, J. M.
Right arrow Articles by Landis Keyes, P.
Biology of Reproduction 60, 740-746 (1999)
©Copyright 1999 Society for the Study of Reproduction, Inc.

Luteal Regression in the Normally Cycling Rat: Apoptosis, Monocyte Chemoattractant Protein-1, and Inflammatory Cell Involvement1

Jennifer M. Bowen2,a,d, Roberto Townsb, Jeffrey S. Warrenc, and P. Landis Keyesa,d

a Departments of Physiology, b Internal Medicine, and c Pathology, and d Reproductive Sciences Program, University of Michigan, Ann Arbor, Michigan 48109


    ABSTRACT
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
In hypophysectomized rats, prolactin induces regression of the corpora lutea. Luteal regression is accompanied by infiltration of monocytes/macrophages, declines in luteal mass and plasma progestins, and increased staining for monocyte chemoattractant protein-1 (MCP-1). We investigated whether similar events are induced during the estrous cycle, after the proestrous prolactin surge. Rats were killed on proestrus or on estrus, and one ovary was frozen for immunohistochemical detection of MCP-1, monocytes/macrophages (ED1-positive), and differentiated macrophages (ED2-positive) and for in situ detection of apoptotic nuclei. Corpora lutea of the current (proestrus) or preceding (estrus) cycle were dissected from the ovaries of additional rats and frozen for the same analyses and for determination of total protein content. In sections of whole ovaries, intensity and distribution of MCP-1 staining were increased in corpora lutea of multiple ages on estrus as compared to proestrus, as were numbers of differentiated macrophages and apoptotic nuclei per high-power field. Sections of isolated corpora lutea showed these increases on estrus, and the number of monocytes/macrophages per high-power field was also significantly increased. Accompanying these inflammatory/immune events, the corpora lutea on estrus showed decreased weight and total protein per corpus luteum, as compared to corpora lutea on proestrus. These changes are consistent with a proposed role for prolactin in the initiation of luteal apoptosis and of a sequence of inflammatory/immune events that accompany regression of the rat corpus luteum during the normal estrous cycle.


    INTRODUCTION
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Prolactin has long been known to have both luteotrophic and luteolytic effects in the rat [17]. While the trophic actions of prolactin have been investigated extensively, the luteolytic effect of the hormone has received less attention and is not well understood. The luteolytic effect of prolactin can be readily demonstrated in hypophysectomized rats: injections of prolactin stimulate rapid regression of the corpora lutea, with concomitant decline in total steroidogenic capacity [8]. We recently reported that this action of prolactin in hypophysectomized rats is associated with inflammatory/immune events in the corpora lutea, namely expression of monocyte chemoattractant protein-1 (MCP-1) and infiltration of monocytes/macrophages, accompanied by a decline in plasma progestins [9]. In the cycling rat, Gaytán et al. [10] showed that blockade of the proestrous prolactin surge with a dopamine agonist decreased the number of monocytes/macrophages found in regressing corpora lutea on the following metestrus. Using a similar approach, Matsuyama et al. [11] reported that blockade of the proestrous prolactin surge reduced the incidence of apoptotic cells in rat corpora lutea. In this investigation, the action of the dopamine agonist could be reversed by administration of prolactin [11]. In the current study, we investigated whether inflammatory/immune events occur in the corpora lutea of normally cycling rats, as we have reported in hypophysectomized prolactin-treated rats [9], and whether the temporal expression of these immune and regressive events is consistent with the proposed luteolytic role of the proestrous prolactin surge [6, 10, 11].


    MATERIALS AND METHODS
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Animals

Adult female Sprague-Dawley rats were obtained from Charles River Breeding Labs. (Portage, MI) at 8 wk of age. Animals were housed under a controlled lighting schedule of 12L:12D (lights-on 0600–1800 h, experiment 1; lights-on 0600–1800 h or 0500–1700 h, experiment 2; lights-on 0500–1700 h, experiment 3). Examination of vaginal epithelium was carried out daily, and only those rats showing at least four consecutive 4-day cycles were used. Monitoring of vaginal epithelium began at 9–11 wk of age, and animals were killed between 11 and 17 wk of age. For experiment 3, rats were obtained from Charles River at 10 wk of age, after the animals had shown 2 consecutive 4-day estrous cycles. These rats were killed after a minimum of 2 consecutive 4-day cycles, at 12–14 wk of age. Animal procedures were approved by the University Committee on the Use and Care of Animals at the University of Michigan.

Experimental Design

In experiment 1, rats were killed either on the morning (0830–1100 h) of proestrus (n = 8) or estrus (n = 5), or on the afternoon (1700–1800 h) of estrus (n = 5). Rats were killed by decapitation following ether anesthesia, and the ovaries were immediately removed and placed on ice. One ovary was frozen in OCT compound (Miles Laboratories, Inc., Elkhart, IN) for immunohistochemistry for monocytes/macrophages (ED1-positive), differentiated macrophages (ED2-positive), and MCP-1 protein and for in situ detection of apoptosis in the corpora lutea of different ages. From the remaining ovary, specific populations or sets of corpora lutea were dissected: on proestrus, the corpora lutea of the current cycle; on estrus, the regressing corpora lutea from the preceding cycle. Once dissected, the corpora lutea from each rat were counted and weighed as a group.

In experiment 2, rats were killed on either the morning (0900–1000 h) of proestrus (n = 7) or the afternoon (1600–1800 h) of estrus (n = 7) as described above, and the ovaries were removed and placed on ice. Specific sets of corpora lutea were dissected from both ovaries: on proestrus, the corpora lutea of the current cycle; on estrus, the regressing corpora lutea from the preceding cycle. The dissected corpora lutea (n = 5–8) from one ovary were frozen as a group for sectioning; the sections were used for immunohistochemistry for monocytes/macrophages, differentiated macrophages, and MCP-1 protein and for in situ detection of apoptosis. The remaining dissected corpora lutea from each rat were counted and weighed as a group.

In experiment 3, rats were killed on either the morning or early afternoon (1000–1300 h) of proestrus (n = 10) or on the afternoon (1500–1700 h) of estrus (n = 10). Rats were killed as described for experiment 1 and the ovaries removed and placed on ice. Corpora lutea of the current cycle (proestrus) or regressing corpora lutea from the preceding cycle (estrus) were dissected from both ovaries, weighed, frozen in liquid nitrogen, and stored at -80°C for later analysis of total protein content.

Antibodies

A description of the polyclonal rabbit anti-rat MCP-1 antibody used for immunohistochemical staining has been published [12]. The monoclonal antibody against rat monocytes/macrophages (clone ED1) used for immunohistochemical staining was obtained from Chemicon International Inc. (Temecula, CA). The specificity of this antibody for rat monocytes/macrophages has been reported previously [13]. The monoclonal antibody against rat differentiated macrophages (clone ED2) was obtained from Serotec via Accurate Chemical & Scientific Corp. (Westbury, NY) and has been shown to specifically recognize differentiated, resident tissue macrophages [14]. Biotinylated secondary antibodies to mouse and rabbit immunoglobulin were obtained from Vector Laboratories (Burlingame, CA).

Immunohistochemistry

Frozen sections of ovaries or isolated corpora lutea were air-dried and fixed in 95% ethanol (10 min); they were then placed in 0.3% H2O2 in methanol (4°C) for 15 min (macrophages) or 30 min (MCP-1) to quench endogenous peroxidase activity. The tissue sections were rinsed three times (5 min each) in PBS containing 1% BSA (fraction V; PBS-1% BSA) and then incubated with 10% normal goat serum for 15 min (macrophages) or 30 min (MCP-1) at 37°C. After this blocking procedure, the sections were rinsed again in PBS-1% BSA and then incubated either with the rabbit anti-rat MCP-1 antibody or with a monoclonal antibody against either rat monocytes/macrophages or differentiated macrophages (1:200 dilution, 30 min at 37°C). After the incubation with primary antibody, the sections were rinsed in PBS-0.1% BSA and then exposed to either biotinylated goat anti-rabbit (MCP-1) or goat anti-mouse (monocytes/macrophages, differentiated macrophages) immunoglobulin (1:200 dilution; 30 min at 37°C). Detection of the antigen-antibody complex was achieved by using a Vector avidin-biotin-peroxidase kit and 3-amino-9 ethylcarbazole as the substrate. The tissue sections were counterstained with hematoxylin, rinsed in distilled water, and dipped in Scott's tap water (a mordant) before being mounted with aqueous mounting medium. MCP-1 staining was graded for intensity and for distribution by two independent observers using coded slides.

Nonspecific staining was assessed by replacement of primary or secondary antibodies with the appropriate serum and was undetectable in all instances.

In Situ Detection of Apoptosis

Nuclei exhibiting DNA fragmentation were detected by in situ hybridization using the ApopTag in situ apoptosis detection kit (Oncor, Gaithersburg, MD). Frozen sections were air-dried and fixed in 10% neutral buffered formalin for 10 min. They were then rinsed in two changes of PBS for 5 min each before being postfixed in ethanol:acetic acid (2:1) for 5 min at -20°C. After postfixing, sections were rinsed again in two changes of PBS and then quenched in 3% H2O2 in PBS for 5 min at room temperature. Sections were rinsed in PBS, and equilibration buffer from the kit was applied to cover each section; the buffer was blotted and replaced with a solution of terminal deoxynucleotide transferase (TdT). The sections were incubated with this enzyme for 1 h at 37°C to allow for tagging of 3' DNA ends with digoxigenin residues. The sections were next placed in stop buffer for 10 min, then rinsed with PBS and incubated with anti-digoxigenin antibody conjugated with peroxidase for 30 min at room temperature. After rinsing in PBS, sections were incubated for 6 min with diaminobenzidine substrate, washed in three changes of distilled water for 1 min each, and then washed in distilled water for 5 min. The sections were counterstained with methyl green for 10 min; this was followed by three washes in distilled water, three washes in 100% butanol, and three washes in xylene before mounting. Negative controls, in which the TdT enzyme solution was replaced with water, were run in every batch of slides stained; this replacement completely eliminated staining. Atretic follicles in whole ovarian sections served as a positive control for apoptotic nuclei. Whole ovarian sections containing these follicles were run in every batch of slides stained.

Assay of Total Luteal Protein

Specific sets of corpora lutea obtained in experiment 3 were homogenized in 500 µl modified RIPA buffer (50 mM Tris-HCl, 150 mM NaCl, 1 mM EGTA) containing detergents (1% Nonidet P-40 and 0.015% sodium deoxycholate) using a tissue homogenizer. The homogenate was diluted (1:30) for assay of total protein using the Bio-Rad Protein Microassay [15]. All standards and samples were assayed in triplicate.

Quantitation of Macrophages and Apoptotic Nuclei

Numbers of macrophages per high-power field were determined for coded slides by visual observation of immunodetectable cells. A light microscope with a x45 objective was used. For experiment 1, one section was examined to determine macrophage numbers, and as many fields as possible (1–4) were counted for each corpus luteum in the section (4–23 corpora lutea). New ovulations on estrus were easily distinguishable in whole ovarian sections and were not included as corpora lutea for this analysis. For experiment 2, two sections of the frozen group of corpora lutea (processed in different staining runs) were examined in the same manner as for experiment 1 (1–3 fields in 3–7 corpora lutea), and an average number of macrophages per high-power field was obtained for each rat.

For quantitation of apoptotic nuclei, two sections from each ovary or group of corpora lutea were examined as above, using coded slides, and an average number of apoptotic nuclei per high-power field was obtained. Again, as many fields as possible were counted for each corpus luteum in these sections, and new ovulations were excluded from analysis of whole ovarian sections.

Statistics

Comparisons among multiple groups were carried out using the Bonferroni multiple comparisons test. Comparisons between two groups were carried out using Student's t-test.


    RESULTS
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Experiment 1

Monocytes/macrophages (ED1-positive) and differentiated macrophages (ED2-positive) were detected by immunohistochemistry in sections of whole ovaries from rats killed on the morning of proestrus (n = 6), the morning of estrus (n = 5), and the afternoon of estrus (n = 5). Cross sections of all corpora lutea, excluding the newly formed corpora lutea on estrus, were used for these analyses, without regard to age of the corpora lutea. Mean ± SEM numbers of luteal monocytes/macrophages (detected by the monoclonal antibody ED1) per high-power field were, respectively, 21.4 ± 2.1, 26.4 ± 4.0, and 27.9 ± 4.1 and were not significantly different among the three time points (p > 0.05; Fig. 1). Numbers of differentiated macrophages (detected by the monoclonal antibody ED2) per high-power field were, respectively, 6.4 ± 1.2, 10.9 ± 1.6, and 16.4 ± 2.5 (p < 0.05, proestrus vs. afternoon of estrus; Fig. 1).



View larger version (18K):
[in this window]
[in a new window]
 
FIG. 1. Numbers of luteal ED1-positive (ED1+) cells and ED2-positive (ED2+) cells per high-power field in sections of whole ovary from rats killed on proestrus, estrus AM, and estrus PM (experiment 1). Different letters indicate significant differences at p < 0.05.

MCP-1 protein detected by immunohistochemistry was differentially distributed among time points. In ovarian sections from rats killed on proestrus (n = 6), MCP-1 was present in the center of the corpora lutea, with the remainder of the structure being essentially devoid of staining (Fig. 2, A and B). In ovarian sections from rats killed on estrus (n = 10), MCP-1 was present throughout the corpora lutea, as well as in the central area of the corpora lutea, as either a diffuse staining or as a number of localized foci of staining (Fig. 2, C–F). Coded slides were identified correctly as estrus or proestrus by two observers on the basis of quantity and distribution of luteal MCP-1 staining. In addition to staining in the corpora lutea, immunodetectable MCP-1 was seen in many follicles and vascular spaces throughout the ovary. This is not surprising, as MCP-1 is a secreted protein made by a number of cell types present in the ovary, including macrophages, epithelial cells, and fibroblasts [16, 17]. We have previously observed that MCP-1 is prevalent in atretic follicles, which also contain macrophages (unpublished results).



View larger version (157K):
[in this window]
[in a new window]
 
FIG. 2. MCP-1 staining (red color) in sections of whole ovary from rats killed on proestrus (A, B) and estrus (C–F; experiment 1). Luteal MCP-1 staining observed in ovarian sections from rats killed on proestrus was limited to a small, intense region of staining in the center of the corpus luteum (A, B), while staining on estrus varied between diffuse, widespread staining throughout the corpora lutea and localized foci of staining distributed throughout the tissue (C–F).

Apoptotic nuclei were detected by in situ hybridization in sections of ovaries from rats killed on the morning of proestrus (n = 6), the morning of estrus (n = 5), and the afternoon of estrus (n = 5). Mean ± SEM numbers of apoptotic nuclei per high-power field were, respectively, 1.6 ± 0.2, 5.3 ± 1.3, and 4.5 ± 0.8 (p < 0.05, proestrus vs. morning of estrus; p < 0.05, proestrus vs. afternoon of estrus; Fig. 3). Cross sections of all corpora lutea, excluding the newly formed corpora lutea on estrus, were used in this analysis, without regard to age of the corpora lutea. Atretic follicles within the same sections exhibited striking numbers of apoptotic nuclei. Frequently, all granulosa cells visible in a follicular section would stain positively for DNA fragmentation (data not shown).



View larger version (31K):
[in this window]
[in a new window]
 
FIG. 3. Numbers of apoptotic cells per high-power field within corpora lutea of multiple ages (whole ovarian sections) from rats killed on proestrus, estrus AM, and estrus PM (experiment 1). Different letters indicate significant differences at p < 0.05.

Weights of individual corpora lutea were as follows: corpora lutea of the current cycle (proestrus) averaged 1.10 ± 0.09 mg (n = 8 rats), versus 0.87 ± 0.02 mg (n = 5 rats) for regressing corpora lutea from the previous cycle (estrus morning) and 0.75 ± 0.04 mg (n = 5 rats) for estrus afternoon (p < 0.05, proestrus vs. morning of estrus; p < 0.05, proestrus vs. afternoon of estrus).

Experiment 2

Monocytes/macrophages (ED1-positive) and differentiated macrophages (ED2-positive) were detected by immunohistochemistry in sections of isolated corpora lutea of the current cycle from rats killed on the morning of proestrus (n = 7) and in sections of isolated regressing corpora lutea from the previous cycle from rats killed on the afternoon of estrus (n = 7). Mean ± SEM numbers of luteal monocytes/macrophages per high-power field were, respectively, 1.4 ± 0.5 and 9.4 ± 0.9 (p < 0.001; Fig. 4). Numbers of differentiated macrophages per high-power field were, respectively, 1.1 ± 0.2 and 6.6 ± 1.6 (p < 0.05; Fig. 4).



View larger version (16K):
[in this window]
[in a new window]
 
FIG. 4. Numbers of luteal ED1+ cells and ED2+ cells per high-power field in sections of isolated corpora lutea from rats killed on proestrus and estrus PM (experiment 2). One asterisk indicates a significant difference at p < 0.05, while three asterisks indicate a significant difference at p < 0.001.

Mean ± SEM numbers of apoptotic nuclei per high-power field were respectively, 1.3 ± 0.2 and 4.7 ± 0.5 (p < 0.001; Fig. 5). Visually, the cells that appeared to be undergoing apoptosis were large round cells typical of the steroidogenic luteal cells. Total number of cell nuclei per high-power field was also determined as an indicator of whether cell shrinkage and tissue compression were taking place. This number was not significantly different between proestrus and the afternoon of estrus (260.3 ± 16 vs. 230.3 ± 16.5, respectively; p > 0.05).



View larger version (16K):
[in this window]
[in a new window]
 
FIG. 5. Numbers of apoptotic cells per high-power field in sections of isolated corpora lutea from rats killed on proestrus or estrus PM (experiment 2). The asterisks indicate a significant difference at p < 0.001.

Weights of individual corpora lutea for experiment 2 were remarkably consistent with those observed in experiment 1. Corpora lutea of the current cycle on proestrus averaged 1.07 ± 0.03 mg (n = 7 rats), versus 0.76 ± 0.03 mg (n = 7 rats) for regressing corpora lutea from the previous cycle on the afternoon of estrus (p < 0.001).

MCP-1 protein detected by immunohistochemistry appeared differentially distributed among time points, as observed for whole ovarian sections in experiment 1. In sections of corpora lutea of the current cycle, MCP-1 was present almost exclusively in the center of the corpora lutea, with the remainder of the structure being essentially devoid of staining. In sections of regressing corpora lutea, MCP-1 was present throughout the corpora lutea. Again, coded slides were identified correctly as estrus or proestrus by two observers, with few misclassifications, based on intensity and distribution of MCP-1 staining.

Experiment 3

The average weight per corpus luteum of the current cycle on proestrus was 1.08 ± 0.02 mg (n = 10 rats); for regressing corpora lutea of the previous cycle on the afternoon of estrus, the value was 0.85 ± 0.03 mg (n = 10 rats; p < 0.001).

Protein per milligram luteal tissue was not different between the corpora lutea on proestrus and corpora lutea on estrus (108.4 ± 6.0 vs. 108.8 ± 5.9 µg/mg luteal tissue; n = 8 at each time point).

When expressed per corpus luteum, the values were 117.7 ± 6.5 vs. 92.9 ± 5.7 µg/corpus luteum, respectively; p < 0.05.


    DISCUSSION
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
The results of this study clearly indicate that regressive changes in the corpus luteum, including changes in MCP-1 and inflammatory cells, are initiated during the time period between proestrus morning (6 h prior to the proestrous prolactin surge) and estrus (16–24 h after the proestrous prolactin surge). These regressive changes are similar to those observed following treatment of hypophysectomized rats with exogenous prolactin [9]; this is consistent with the idea that the proestrous prolactin surge might be the stimulus for inflammatory/immune events occurring in the corpora lutea during the estrous cycle.

The recruitment of inflammatory/immune cells into the corpus luteum at the time of luteal regression has been observed in a number of species [1824]; however, the underlying stimuli and mechanisms for this recruitment remain largely unknown. The chemokine, MCP-1, may have a prominent role. MCP-1 is expressed in the corpora lutea of several species [2528]. It has multiple roles as a chemoattractant for monocytes, and as a factor that induces the production of reactive oxygen intermediates and lysosomal enzymes by monocytes [2931]. The presence of MCP-1 staining at higher intensity and altered distribution within the corpora lutea on estrus compared to proestrus suggests that the presence of monocytes/macrophages in the corpus luteum at regression is not incidental and is associated with changes in expression of MCP-1. We have previously reported a similar association in regressing corpora lutea at the end of pregnancy [28], in regressing corpora lutea the day after mating [28], and in corpora lutea regressing due to the acute actions of prolactin injected in hypophysectomized rats [9].

Although intense staining for MCP-1 is observed in both the regressing corpora lutea of cycling rats and the corpora lutea of hypophysectomized rats treated with prolactin [9], we observe differential expression of cell markers for monocytes/macrophages in these animals. In hypophysectomized rats, although the number of monocytes/macrophages per high-power field is greatly increased by 72 h after onset of prolactin treatment [9], virtually none of these cells are positive for the ED2 antigen (based on personal communications). In contrast, in the current study we observed large numbers of ED2-positive cells, up to two thirds of the entire ED1-positive population. Expression of the ED2 antigen correlates with differentiated, resident macrophages, and adhesion is necessary to induce its expression [14]. The ED2 antigen is not expressed on monocytes, nor is it expressed on recently recruited inflammatory macrophages [14], which may explain the lack of staining in corpora lutea of rats treated with prolactin. According to van Rooijen et al. [32], it may take a week for ED1-positive cells to express the ED2 antigen. We observed larger numbers of both ED1- and ED2-positive cells per high-power field when regressing corpora lutea of all ages were addressed (experiment 1) than in corpora lutea entering regression on estrus (experiment 2). In addition, significant numbers of these immune cells were already present on proestrus when all regressing corpora lutea were used for analysis (experiment 1). This suggests that the infiltration of immune cells that occurs between proestrus and estrus is not transient and that it may continue as corpora lutea continue to regress, leading to larger numbers of monocytes/macrophages and resident, differentiated macrophages per high-power field in older corpora lutea.

We do observe increases in ED2-positive cells in corpora lutea entering regression on estrus, as compared to proestrus. It is possible that the time required for recruited macrophages to express the ED2 antigen is decreased in cycling rats as compared to hypophysectomized rats due to differences in the steroid milieu. The hypophysectomized rat, which lacks pituitary trophic hormones, has a low level of production of estradiol [8] and of glucocorticoids [33]. In addition, the absence of prolactin results in the conversion of progesterone to the inactive metabolite 20{alpha}-dihydroprogesterone by the corpora lutea [8, 34]. Thus the differential production of adrenal and ovarian steroids in the cycling rat as compared to the hypophysectomized rat may affect the differentiation of macrophages, at least some lineages of which express receptors for estrogens, androgens, and glucocorticoids [3537]. The significant increase in numbers of ED2-positive macrophages in corpora lutea on estrus, as compared to proestrus, raises questions about the role of these cells in the tissue. The presence of ED2-positive cells may indicate increased activation of macrophages. Determining the level of expression of major histocompatibility complex (MHC) II molecules on these cells might provide further evidence as to whether ED2-positive cells have enhanced functional status. Brännström et al. [23] reported increased levels of MHC II-positive cells on Day 15 of pseudopregnancy and after Day 15 of pregnancy in the rat. However, the incidence of MHC II-positive cells did not correlate with changes in ED2-positive cells. We have observed recently that the administration of dexamethasone to prolactin-treated hypophysectomized rats is associated with an increase in the number of ED2-positive cells present in the corpora lutea (based on personal communications). Dexamethasone has previously been shown to increase the number of ED2-positive colonies arising during culture of bone marrow stromal cells of rats [38, 39], as has progesterone [39].

The physiological destruction of the corpora lutea in the rat is an orderly, choreographed process. Rat corpora lutea regress gradually over a period of several cycles [40] and are capable of a transient resurgence in growth in the case of a subsequent pregnancy [41]. In the hypophysectomized rat it is clear that the corpora lutea remain steroidogenically active, producing predominantly 20{alpha}-dihydroprogesterone [8, 9]. While the inflammatory/immune events observed on estrus are associated with rapid physical destruction of the corpora lutea, measured by loss of luteal wet weight and total protein, the protein per milligram of tissue does not change over this interval (experiment 3), suggesting that the composition of the tissue remains stable, even as the tissue undergoes regression. One interpretation of the observations cited above is that the process of luteal regression in the rat involves the targeted deletion of individual cells, perhaps through apoptosis, leaving other cells in a relatively healthy steroidogenic condition.

An increase in apoptotic cell death in regressing corpora lutea on estrus suggests that apoptosis is one mechanism by which deletion of tissue occurs. Increases in luteal apoptosis after prolactin administration, or decreases after blockade of prolactin, have been previously reported [11]. It is also possible that macrophages play some role in deletion of luteal tissue, perhaps by phagocytosis of cells [24] or by the killing of cells through secreted products such as lysozyme and reactive oxygen intermediates [42]. Activated macrophages also produce cytokines such as tumor necrosis factor {alpha} [43], which is present in corpora lutea at regression [20, 44, 45] and which has been shown to cause cell death in corpora lutea and luteal cells maintained in culture [46, 47]. Apoptosis, therefore, may occur first in response to a prolactin signal and then be perpetuated in the regressing tissue by the actions of macrophages that are also recruited in response to the prolactin signal. Evidence for continued tissue deletion after repeated exposures to prolactin is provided by the whole ovarian sections (experiment 1), in which corpora lutea of several different ages and regressive states were present. In these sections, despite this heterogeneity, a significant increase in apoptotic nuclei per high-power field was seen on the morning of estrus as compared to proestrus, and this increase was remarkably similar to that seen in corpora lutea first entering regression on estrus (experiment 2). This suggests that each prolactin surge might initiate a new round of apoptosis in all regressing corpora lutea. If this is so, then administration of prolactin every 12 h, as carried out in previous experiments with hypophysectomized rats [8, 9], may lead to a maximal rate of tissue deletion. While the non-ED2-positive macrophages recruited in response to prolactin are associated with rapid regression of the corpus luteum, when prolactin is delivered every 12 h [9], it is altogether possible that increased differentiation and activation of macrophages are required for similarly paced regression following one, solitary prolactin signal, as occurs on proestrus during the estrous cycle. At no time was the amount of apoptosis observed in the corpora lutea as dramatic and widespread as we observed in collapsing atretic follicles in the same sections, which is further evidence for a slow and controlled process of tissue deletion in the corpora lutea.

This study is the first to examine a single, most recent, generation of corpora lutea before (proestrus) and immediately after (estrus) the putative signal for regression as well as examining all populations of regressing corpora lutea. We have found that inflammatory/immune and regressive events are initiated (MCP-1 changes; monocyte/macrophage infiltration; apoptosis) and reinitiated (MCP-1 changes; apoptosis) at this time. The observed increases in monocyte/macrophage numbers and in apoptotic nuclei are consistent with the findings from previous studies [10, 11]. The timing of onset of these events is consistent with a role for the proestrous prolactin surge in initiating regression. However, other hormones, such as ovarian steroids and LH, are also elevated during this time period. It is possible that one or a combination of these factors participate in the initiation of inflammatory/immune events in corpora lutea observed on estrus. The recruitment of monocytes/macrophages to regressing corpora lutea entering regression between proestrus and estrus is consistent with the effects of prolactin treatment in the hypophysectomized rat [9]; however, the differentiation state of the macrophages present is altered, raising the question of what this differentiation means in terms of macrophage function in the tissue. The role of macrophages and other inflammatory cells in luteal regression remains an intriguing problem for future investigation.


    ACKNOWLEDGMENTS
 
The authors gratefully acknowledge R.K. Brabec and R.W. Crawford of the P30 Center Morphology Core Facility for their assistance.


    FOOTNOTES
 
1 This work was supported by NIH HD-33478. Support was also provided by the Morphology Core Facility of the P30 Center for the Study of Reproduction (NIH HD-18258). Back

2 Correspondence: J.M. Bowen, Department of Physiology, University of Michigan, 7627 Medical Sciences II Building, Ann Arbor, MI 48109–0622. FAX: 734 936 8813; bowenjm{at}umich.edu Back

Accepted: October 27, 1998.

Received: July 1, 1998.


    REFERENCES
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 

  1. Rothchild I. The regulation of the mammalian corpus luteum. Recent Prog Horm Res 1981; 37:183–298.
  2. Gibori G, Khan I, Warshaw ML, McLean MP, Puryear TK, Nelson S, Durkee TJ, Azhar S, Steinschneider A, Rao MC. Placental-derived regulators and the complex control of luteal cell function. Recent Prog Horm Res 1988; 44:377–429.
  3. Malven PV. Luteotrophic and luteolytic responses to prolactin in hypophysectomized rats. Endocrinology 1969; 84:1224–1229.[Abstract/Free Full Text]
  4. Malven PV, Sawyer CH. A luteolytic action of prolactin in hypophysectomized rats. Endocrinology 1966; 79:268–274.[Abstract/Free Full Text]
  5. Malven PV, Cousar GJ, Row EH. Structural luteolysis in hypophysectomized rats. Am J Physiol 1969; 216:421–424.
  6. Wüttke W, Meites J. Luteolytic role of prolactin during the estrous cycle of the rat. Proc Soc Exp Biol Med 1971; 137:988–991.[CrossRef][Medline]
  7. Billeter E, Flückiger E. Evidence for a luteolytic function of prolactin in the intact cyclic rat using 2-Br-{alpha}-ergokryptine (CB 154). Experientia 1971; 27:464–465.[CrossRef][Medline]
  8. Taya K, Greenwald GS. In vivo and in vitro ovarian steroidogenesis in the long term hypophysectomized rat. Endocrinology 1982; 110:390–397.[Abstract/Free Full Text]
  9. Bowen JM, Keyes PL, Warren JS, Townson DH. Prolactin-induced regression of the rat corpus luteum: expression of monocyte chemoattractant protein-1 and invasion of macrophages. Biol Reprod 1996; 54:1120–1127. Published Erratum appears in Biol Reprod 55:224.[Abstract]
  10. Gaytán F, Morales C, Bellido C, Aguilar E, Sánchez-Criado JE. Role of prolactin in the regulation of macrophages and in the proliferative activity of vascular cells in newly formed and regressing rat corpora lutea. Biol Reprod 1997; 57:478–486.[Abstract]
  11. Matsuyama S, Chang K-T, Kanuka H, Ohnishi M, Ikeda A, Nishihara M, Takahashi M. Occurrence of deoxyribonucleic acid fragmentation during prolactin-induced structural luteolysis in cycling rats. Biol Reprod 1996; 54:1245–1251.[Abstract]
  12. Jones ML, Mulligan MS, Flory CM, Ward PA, Warren JS. Potential role of monocyte chemoattractant protein 1/JE in monocyte/macrophage-dependent IgA immune complex alveolitis in the rat. J Immunol 1992; 149:2147–2154.[Abstract]
  13. Dijkstra CD, Döpp EA, Joling P, Kraal G. The heterogeneity of mononuclear phagocytes in lymphoid organs: distinct macrophage subpopulations in the rat recognized by monoclonal antibodies ED1, ED2 and ED3. Immunology 1985; 54:589–599.[Medline]
  14. Barbé E, Damoiseaux JGMC, Döpp EA, Dijkstra CD. Characterization and expression of the antigen present on resident rat macrophages recognized by monoclonal antibody ED2. Immunobiology 1990; 182:88–99.[Medline]
  15. Bio-Rad/Life Science Research Products Catalog 1997; 350–352.
  16. Leonard EJ, Yoshimura T. Human monocyte chemoattractant protein-1 (MCP-1). Immunol Today 1990; 11:97–101.[CrossRef][Medline]
  17. Mukaida N, Harada A, Yasumoto K, Matsushima K. Properties of pro-inflammatory cell type-specific leukocyte chemotactic cytokines, interleukin 8 (IL-8) and monocyte chemotactic and activating factor (MCAF). Microbiol Immunol 1992; 36:773–789.[Medline]
  18. Paavola LG. The corpus luteum of the guinea pig. Fine structure at the time of maximum progesterone secretion and during regression. Am J Anat 1977; 150:565–604.[CrossRef][Medline]
  19. Kirsch TM, Friedman AC, Vogel RL, Flickinger GL. Macrophages in corpora lutea of mice: characterization and effects on steroid secretion. Biol Reprod 1981; 25:629–638.[Abstract]
  20. Bagavandoss P, Wiggins RC, Kunkel SL, Remick DG, Keyes PL. Tumor necrosis factor production and accumulation of inflammatory cells in the corpus luteum of pseudopregnancy and pregnancy in rabbits. Biol Reprod 1990; 42:367–376.[Abstract]
  21. Lei ZM, Chegini N, Rao ChV. Quantitative cell composition of human and bovine corpora lutea from various reproductive states. Biol Reprod 1991; 44:1148–1156.[Abstract]
  22. Hehnke KE, Christenson LK, Ford SP, Taylor M. Macrophage infiltration into the porcine corpus luteum during prostaglandin-F2{alpha}-induced luteolysis. Biol Reprod 1994; 50:10–15.[Abstract]
  23. Brännström M, Giesecke L, Moore IC, Van Den Heuvel CJ, Robertson SA. Leukocyte subpopulations in the rat corpus luteum during pregnancy and pseudopregnancy. Biol Reprod 1994; 50:1161–1167.[Abstract]
  24. Takaya R, Fukaya T, Sasano H, Suzuki T, Tamura M, Yajima A. Macrophages in normal cycling human ovaries; immunohistochemical localization and characterization. Hum Reprod 1997; 12:1508–1512.[Abstract/Free Full Text]
  25. Hosang K, Knoke I, Klaudiny J, Wempe F, Wüttke W, Scheit KH. Porcine luteal cells express monocyte chemoattractant protein-1 (MCP-1): analysis by polymerase chain reaction and cDNA cloning. Biochem Biophys Res Commun 1994; 199:962–968.[CrossRef][Medline]
  26. Tsai SJ, Juengel JL, Wiltbank MC. Hormonal regulation of monocyte chemoattractant protein-1 messenger ribonucleic acid expression in corpora lutea. Endocrinology 1997; 138:4517–4520.[Abstract/Free Full Text]
  27. Haworth JD, Rollyson MK, Silva P, McIntush EW, Niswender GD. Messenger ribonucleic acid encoding monocyte chemoattractant protein-1 is expressed by the ovine corpus luteum in response to prostaglandin F2{alpha}. Biol Reprod 1998; 58:169–174.[Abstract/Free Full Text]
  28. Townson DH, Warren JS, Flory CM, Naftalin DM, Keyes PL. Expression of monocyte chemoattractant protein-1 in the corpus luteum of the rat. Biol Reprod 1996; 54:513–520.[Abstract]
  29. Zachariae COC, Anderson AO, Thompson HL, Appella E, Mantovani A, Oppenheim JJ, Matsushima K. Properties of monocyte chemotactic and activating factor (MCAF) purified from a human fibrosarcoma cell line. J Exp Med 1990; 171:2177–2182.[Abstract/Free Full Text]
  30. Fuentes ME, Durham SK, Swerdel MR, Lewin AC, Barton DS, Megill JR, Bravo R, Lira SA. Controlled recruitment of monocytes and macrophages to specific organs through transgenic expression of monocyte chemoattractant protein-1. J Immunol 1995; 155:5769–5776.[Abstract]
  31. Gu L, Rutledge B, Fiorillo J, Ernst C, Grewal I, Flavell R, Gladue R, Rollins B. In vivo properties of monocyte chemoattractant protein-1. J Leukocyte Biol 1997; 62:577–580.[Abstract]
  32. van Rooijen N, Kors N, van der Ende M, Dijkstra CD. Depletion and repopulation of macrophages in spleen and liver of rat after intravenous treatment with liposome-encapsulated dichloromethylene diphosphonate. Cell Tissue Res 1990; 260:215–222.[CrossRef][Medline]
  33. Porter JC, Klaiber MS. Corticosterone secretion in rats as a function of ACTH input and adrenal blood flow. Am J Physiol 1965; 209:811–814.
  34. Albarracin CT, Parmer TG, Duan WR, Nelson SE, Gibori G. Identification of a major prolactin-regulated protein as 20{alpha}-hydroxysteroid dehydrogenase: coordinate regulation of its activity, protein content, and messenger ribonucleic acid expression. Endocrinology 1994; 134:2453–2460.[Abstract/Free Full Text]
  35. Frazier-Jessen MR, Kovacs EJ. Estrogen modulation of JE/Monocyte chemoattractant protein-1 mRNA expression in murine macrophages. J Immunol 1995; 154:1838–1845.[Abstract]
  36. Prins GS, Birch L, Greene GL. Androgen receptor localization in different cell types of the adult rat prostate. Endocrinology 1991; 129:3187–3199.[Abstract/Free Full Text]
  37. Schultz R, Isola J, Parvinen M, Honkaniemi J, Wikström A-C, Gustafsson J-Å, Pelto-Huikko M. Localization of the glucocorticoid receptor in testis and accessory sexual organs of male rat. Mol Cell Endocrinol 1993; 95:115–120.[CrossRef][Medline]
  38. Herbertson A, Aubin JE. Dexamethasone alters the subpopulation make-up of rat bone marrow stromal cell cultures. J Bone Min Res 1995; 10:285–294.[Medline]
  39. Ishida Y, Tertinegg I, Heersche JNM. Progesterone and dexamethasone stimulate proliferation and differentiation of osteoprogenitors and progenitors for adipocytes and macrophages in cell populations derived from adult rat vertebrae. J Bone Min Res 1996; 11:921–930.[Medline]
  40. Long JA, Evans HM. The estrous cycle of the rat and its associated phenomena. Mem Univ Calif 1922; 6:1–148.
  41. Bruce NW, Meyer GT, Dharmarajan AM. Rate of blood flow and growth of the corpora lutea of pregnancy and of previous cycles throughout pregnancy in the rat. J Reprod Fertil 1984; 71:445–452.[Abstract/Free Full Text]
  42. Johnston RB. Current concepts: immunology; monocytes and macrophages. New Engl J Med 1988; 318:747–752.[Medline]
  43. Beutler B, Cerami A. Cachectin (tumor necrosis factor): a macrophage hormone governing cellular metabolism and inflammatory response. Endocr Rev 1988; 9:57–66.[Abstract/Free Full Text]
  44. Bagavandoss P, Kunkel SL, Wiggins RC, Keyes PL. Tumor necrosis factor-{alpha} (TNF-{alpha}) production and localization of macrophages and T lymphocytes in the rabbit corpus luteum. Endocrinology 1988; 122:1185–1187.[Abstract/Free Full Text]
  45. Roby KF, Weed J, Lyles R, Terranova PF. Immunological evidence for a human ovarian tumor necrosis factor-{alpha}. J Clin Endocrinol Metab 1990; 71:1096–1102.[Abstract/Free Full Text]
  46. Abdo MA, Dharmarajan AM. Role of tumor necrosis factor-alpha in corpus luteum regression. In: Proceedings of the 8th Annual Combined Biological Sciences Meeting; 1997; Perth. Abstract 16.
  47. Benyo DF, Pate JL. Tumor necrosis factor-{alpha} alters bovine luteal cell synthetic capacity and viability. Endocrinology 1992; 130:854–860.[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
EndocrinologyHome page
B. Liu and L. A. Arbogast
Phosphorylation State of Tyrosine Hydroxylase in the Stalk-Median Eminence Is Decreased by Progesterone in Cycling Female Rats
Endocrinology, April 1, 2008; 149(4): 1462 - 1469.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
M. Kobara, N. Sunagawa, M. Abe, N. Tanaka, H. Toba, H. Hayashi, N. Keira, T. Tatsumi, H. Matsubara, and T. Nakata
Apoptotic myocytes generate monocyte chemoattractant protein-1 and mediate macrophage recruitment
J Appl Physiol, March 1, 2008; 104(3): 601 - 609.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
J. Xu, F. Xu, J. D. Hennebold, T. A. Molskness, and R. L. Stouffer
Expression and Role of the Corticotropin-Releasing Hormone/Urocortin-Receptor-Binding Protein System in the Primate Corpus Luteum during the Menstrual Cycle
Endocrinology, November 1, 2007; 148(11): 5385 - 5395.
[Abstract] [Full Text] [PDF]


Home page
ReproductionHome page
A. A Goyeneche, J. M Harmon, and C. M Telleria
Cell death induced by serum deprivation in luteal cells involves the intrinsic pathway of apoptosis
Reproduction, January 1, 2006; 131(1): 103 - 111.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
A. A. Goyeneche, I. L. Martinez, R. P. Deis, G. Gibori, and C. M. Telleria
In Vivo Hormonal Environment Leads to Differential Susceptibility of the Corpus Luteum to Apoptosis In Vitro
Biol Reprod, June 1, 2003; 68(6): 2322 - 2330.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
M. Abdo, S. Hisheh, and A. Dharmarajan
Role of Tumor Necrosis Factor-Alpha and the Modulating Effect of the Caspases in Rat Corpus Luteum Apoptosis
Biol Reprod, April 1, 2003; 68(4): 1241 - 1248.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
A. A. Goyeneche, R. P. Deis, G. Gibori, and C. M. Telleria
Progesterone Promotes Survival of the Rat Corpus Luteum in the Absence of Cognate Receptors
Biol Reprod, January 1, 2003; 68(1): 151 - 158.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
J. K. Pru, I. R. Hendry, J. S. Davis, and B. R. Rueda
Soluble Fas Ligand Activates the Sphingomyelin Pathway and Induces Apoptosis in Luteal Steroidogenic Cells Independently of Stress-Activated p38MAPK
Endocrinology, November 1, 2002; 143(11): 4350 - 4357.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
K. Nagaosa, A. Shiratsuchi, and Y. Nakanishi
Determination of Cell Type Specificity and Estrous Cycle Dependency of Monocyte Chemoattractant Protein-1 Expression in Corpora Lutea of Normally Cycling Rats in Relation to Apoptosis and Monocyte/Macrophage Accumulation
Biol Reprod, November 1, 2002; 67(5): 1502 - 1508.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
A. A. Goyeneche, V. Calvo, G. Gibori, and C. M. Telleria
Androstenedione Interferes in Luteal Regression by Inhibiting Apoptosis and Stimulating Progesterone Production
Biol Reprod, May 1, 2002; 66(5): 1540 - 1547.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
K. H. H. Wong, H. Negishi, and E. Y. Adashi
Expression, Hormonal Regulation, and Cyclic Variation of Chemokines in the Rat Ovary: Key Determinants of the Intraovarian Residence of Representatives of the White Blood Cell Series
Endocrinology, March 1, 2002; 143(3): 784 - 791.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
D. H. Townson, C. L. O'Connor, and J. K. Pru
Expression of Monocyte Chemoattractant Protein-1 and Distribution of Immune Cell Populations in the Bovine Corpus Luteum Throughout the Estrous Cycle
Biol Reprod, February 1, 2002; 66(2): 361 - 366.
[Abstract] [Full Text] [PDF]


Home page
LupusHome page
A R Buckley
Prolactin, a lymphocyte growth and survival factor
Lupus, October 1, 2001; 10(10): 684 - 690.
[Abstract] [PDF]


Home page
Biol. Reprod.Home page
F. Gaytan, C. Bellido, C. Morales, and J.E. Sanchez-Criado
Luteolytic Effect of Prolactin Is Dependent on the Degree of Differentiation of Luteal Cells in the Rat
Biol Reprod, August 1, 2001; 65(2): 433 - 441.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
K. S. Simpson, M. J. Byers, and T. E. Curry Jr.
Spatiotemporal Messenger Ribonucleic Acid Expression of Ovarian Tissue Inhibitors of Metalloproteinases throughout the Rat Estrous Cycle
Endocrinology, May 1, 2001; 142(5): 2058 - 2069.
[Abstract] [Full Text]


Home page
Biol. Reprod.Home page
K. K. Olson, L. E. Anderson, M. C. Wiltbank, and D. H. Townson
Actions of Prostaglandin F2{{alpha}} and Prolactin on Intercellular Adhesion Molecule-1 Expression and Monocyte/Macrophage Accumulation in the Rat Corpus Luteum
Biol Reprod, March 1, 2001; 64(3): 890 - 897.
[Abstract] [Full Text]


Home page
Biol. Reprod.Home page
E. Asselin, G. A. Johnson, T. E. Spencer, and F. W. Bazer
Monocyte Chemotactic Protein-1 and -2 Messenger Ribonucleic Acids in the Ovine Uterus: Regulation by Pregnancy, Progesterone, and Interferon-{{tau}}
Biol Reprod, March 1, 2001; 64(3): 992 - 1000.
[Abstract] [Full Text]


Home page
Biol. Reprod.Home page
K. K. Olson and D. H. Townson
Prolactin-Induced Expression of Intercellular Adhesion Molecule-1 and the Accumulation of Monocytes/Macrophages During Regression of the Rat Corpus Luteum
Biol Reprod, June 1, 2000; 62(6): 1571 - 1578.
[Abstract] [Full Text]


Home page
Biol. Reprod.Home page
J. M. Bowen and P. L. Keyes
Repeated Exposure to Prolactin Is Required to Induce Luteal Regression in the Hypophysectomized Rat
Biol Reprod, April 1, 2000; 63(4): 1179 - 1184.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
H. Inadera, T. Sekiya, T. Yoshimura, and K. Matsushima
Molecular Analysis of the Inhibition of Monocyte Chemoattractant Protein-1 Gene Expression by Estrogens and Xenoestrogens in MCF-7 Cells
Endocrinology, January 1, 2000; 141(1): 50 - 59.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
J. M. Bowen and P. L. Keyes
The Proestrous Prolactin Surge Is Not the Sole Initiator of Regressive Changes in Corpora Lutea of Normally Cycling Rats
Biol Reprod, November 1, 1999; 61(5): 1208 - 1215.
[Abstract] [Full Text]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow My Folders
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bowen, J. M.
Right arrow Articles by Landis Keyes, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bowen, J. M.
Right arrow Articles by Landis Keyes, P.
Agricola
Right arrow Articles by Bowen, J. M.
Right arrow Articles by Landis Keyes, P.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS